Climb Bio Inc. (CLYM) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Climb Bio Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$10.12
+5.75% today
Market cap
$550M
Overall quality
46/100
Kronos AI 30-day
+37.2%
8 of 8 simulated paths end higher
Climb Bio Inc. (CLYM) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $550M. It trades at $10.12, up 5.75% today. Its overall quality score is 46 out of 100, ranked against the whole US market. 12 analysts' average target of $28.60 implies +182.6% from today's price. Kronos AI's 30-day forecast is +37.2% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $28.60 |
| Low – high | $18.00 – $40.00 |
| Analysts | 12 |
| Upside to average | +182.6% |
Kronos AI 30-day forecast
| Expected close | $13.13 (+37.2%) |
| Likely range | +27.3% … +44.3% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 42 |
| Solvency | 58 |
| Growth | 38 |
| Overall | 46 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.